Shenzhen Chipscreen Biosciences Co., Ltd.

¥21.12As of Sun 8 Nov 2026, 12:00 UTC
SSE:688321Healthcare
Country China
PE (Fwd) •••
TSR 7Y CAGR (15.76%)
Div yield 0.27%
ROE 3.39%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.74
PE TTM 126.8
TSR TTM (31.46%)
Mkt cap ¥9.342B
ROIC 4.67%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥22
5.21%
(54.95%)
Hold 11|4|4|4|12
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.38
0.37
0.42
0.44
(1.76%)
1.34%
12.77%
21.39%
Revenue¥M
651.7
635.2
653.8
664.3
8.73%
4.09%
9.31%
7.31%
Peers (US$1.400B)
Cap (US$)
PE
1.450B
253.8x
1.330B
—
1.414B
70.86x
Capital
TTM
5Y
10Y
Leveragex
2.262
1.515
1.060
EBIT/Intx
1.068
0.114
0.113
Own earn%
2.55
51.28
50.63
Sh yield%
10.98
26.42
31.79
Owners
Insiders/Inst%
14.41
72.08
Short interest%
1.43
SBC / revenue%
1.30
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
7–15
$1 testx
0.0
Incr. ROIC%
2